KLF4 blocks the G1/S transition and inhibits cell cycle progression after DNA damage by recruiting p53 to the CDKN1A promoter, and thereby inducing CDKN1A (the gene encoding the CDK inhibitor p21) in colon cancer [128,129]. Here, CDKN1A is linked to malignant colon neoplasm.